Pasithea Therapeutics Corp. (KTTAW) Current Assets (2020 - 2026)

Pasithea Therapeutics has disclosed Current Assets across 7 years of filings, most recently posting $48.2 million for Q2 2026.

• In Q2 2026, Current Assets rose 458.6% year-over-year to $48.2 million; the TTM figure through Jun 2026 stood at $48.2 million (up 458.6% YoY), while the FY2025 annual figure was $56.5 million, up 666.24% from the prior year.
• Current Assets came in at $48.2 million for Q2 2026 at Pasithea Therapeutics, down from $52.7 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $56.5 million in Q4 2025 to a low of $5.5 million in Q3 2025.
• Average Current Assets over 5 years is $27.3 million, with a median of $24.4 million recorded in 2023.
• Year-over-year, Current Assets slumped 69.17% in 2024 and soared 760.93% in 2026.
• Over 5 years, Current Assets stood at $34.1 million in 2022, then slumped by 51.02% to $16.7 million in 2023, then slumped by 55.86% to $7.4 million in 2024, then jumped by 666.24% to $56.5 million in 2025, then retreated by 14.55% to $48.2 million in 2026.
• Per Business Quant data, the three most recent Current Assets figures were $48.2 million in Q2 2026, $52.7 million in Q1 2026, and $56.5 million in Q4 2025.